Subsidiaries and holdings
- THYMOLUX25.04%
KANEKA EUROGENTEC
ActiveSummary
The computed 12-month bankruptcy probability of KANEKA EUROGENTEC is 2.7% (moderate). The 2026 annual accounts show negative equity (-€4,334) and a net result of -€20.4m. Equity has been shrinking by about 11% per year since 2019. The company has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 18-05-1985 Normal situation
- Activity
- Research and development on biotechnology NACE 72101and 4 others
- Joint committee
- 207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 31-03-2026
- Establishment units
- 2.027.405.710 4102 Seraing, since 01-10-1985
- 2.137.656.207 4102 Seraing, since 01-08-2003and 1 other
- Financial year end
- 31 March
- Peppol
- Reachable since 11-12-2025
Board and ownership
Board
- Lieven JANSSENSDirector · since 22-06-2022
- Masanobu SUGAWARADirector · since 22-06-2022
- Masaaki KIMURADirector · since 26-06-2024
- Auditor
- KPMG Réviseurs d'Entreprises BV/SRL
Shareholders
- Kaneka Europe Holding Company100%31-03-2025 annual accounts of Kaneka Europe Holding Company
- Kaneka Corporationconsolidatesannual accounts 31-03-2026
- Holdings
- Shares in 7 companies including EUROGENTEC FRANCE and EUROGENTEC LTD
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.7%
Annual accounts to 31-03-2026
- Turnover
- €49.4m
- ▼ 26.9%
- Loss
- €20.4m
- ▼ 43.8%
- Equity
- -€4,334
- Total assets
- €115.4m
- ▼ 8.5%
- Employees on 31-03-2026
- 383
- ▼ 6.1%
- Negative equity on 31-03-2026
Standalone figures, without subsidiaries
Score breakdownraises riskNegative equity -€4,334Loss of €20.4m, the second in a row (financial year 2026)Liquidity: current ratio 0.70, cash €628,642Founded in 1985Show the evidence
Checked score
Score 2026
49
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 12% of all companies
Financial strength · tick: 2025
Weak
Solvency
25-16
equity 0.0% of total assets
Liquidity
29+2
short-term debt 44.6% · cash 0.5%
Profitability
0=
return on assets -17.7%
Bankruptcy probability within 12 months
2.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025lowest value
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025
08-2025: 1.4%▲ +1.1 percentage points vs 07-2025
09-2025: 1.4%● unchanged vs 08-2025
10-2025: 1.4%● unchanged vs 09-2025
11-2025: 1.4%● unchanged vs 10-2025
12-2025: 1.4%● unchanged vs 11-2025
01-2026: 1.4%● unchanged vs 12-2025
02-2026: 1.4%● unchanged vs 01-2026
03-2026: 1.4%● unchanged vs 02-2026
04-2026: 1.4%● unchanged vs 03-2026
05-2026: 1.4%● unchanged vs 04-2026
06-2026: 1.4%● unchanged vs 05-2026
07-2026: 1.4%● unchanged vs 06-2026
08-2026: 2.7%▲ +1.3 percentage points vs 07-2026highest value
09-2026: 2.7%● unchanged vs 08-2026highest value
10-2026: 2.7%● unchanged vs 09-2026highest value
11-2026: 2.7%● unchanged vs 10-2026highest value
No credit on open account
Liquidity is insufficient, with a current ratio of 0.7 (0.69 in 2025), below 1. Short-term debt is 44.6% and cash 0.5% of total assets. Equity is negative.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (all companies). It does better than 10% of them on solvency, 26% on liquidity, 4% on profitability and 9% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
raises riskneutral
raises risk · Negative equity
The 2026 annual accounts show negative equity and a net loss.
NBB · annual accounts 2026Equity per financial year
1920212223242526
2019 to 2026 · latest year -€4,334
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 17-07-2026, 106 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2026
106 days early
2025
106 days early
2024
100 days early
2023
99 days early
2022
103 days early
2021
18 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 83 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 20 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-03-2027 year end31-10-2027 deadline
Key points
- Risk: Negative equitydebts exceed assets in financial year 2026 -€4,334 View
- Risk: 3 loss-making years in a rowloss in financial year 2026 -€20.4m View
- Positive: Largest employer in the province of Liège, Research and development sectorin the Checked rankings No. 1 View
- Positive: Result rose in 2026from -€36.3m to -€20.4m ▲ 43.8% View
- Board changedlatest change 24-06-2026 · 5 in office 1 joined · 1 left View
- Positive: Filed on time since financial year 2022accounts within the deadline every year 5 years View
- EU supportawarded from 2022 to 2025 €133,435 View
Recent changes
- · Gazette deed Admissions: Anne Gregov, Kotaro Oshima and 9 others
- · Gazette deed Resignation: Kan OKABE (director)Appointment: Hiroyuki NISHIMOTО (director)
- · Gazette deed Resignations & appointments
Companies linked to KANEKA EUROGENTEC
Comparable companies
These companies have the same main activity as KANEKA EUROGENTEC: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €21m and €417m, founded between 1979 and 2013.
| Company | Total assets | Turnover |
|---|---|---|
| KANEKA EUROGENTEC Seraing | €115.4m | €49.4m |
| Baxter R and D Europe Lessines | €52.7m | €58.8m |
| VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY Gent | €323.7m | €52.6m |
| ABLYNX Gent | €417.3m | €147.9m |
| BIOCARTIS Mechelen | €61.8m | €48.2m |
| DIAGENODE Seraing | €21.1m | €11.9m |
| Enovalife Evere | €21.9m | €25.2m |
Key facts about KANEKA EUROGENTEC
- What is the company number of KANEKA EUROGENTEC?
- The company number of KANEKA EUROGENTEC is 0427.348.346. The VAT number is the same number with BE in front: BE 0427.348.346.
- Where is KANEKA EUROGENTEC based?
- The registered office is at Rue du Bois St-Jean 5, 4102 Seraing.Company details
- What does KANEKA EUROGENTEC do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of KANEKA EUROGENTEC?
- The legal form of KANEKA EUROGENTEC is Public limited company (NV).
- When was KANEKA EUROGENTEC founded?
- KANEKA EUROGENTEC was founded on 18-05-1985.
- Is KANEKA EUROGENTEC still active?
- Yes, KANEKA EUROGENTEC is an active enterprise in the KBO register.
- How many employees does KANEKA EUROGENTEC have?
- KANEKA EUROGENTEC had an average of 379.2 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does KANEKA EUROGENTEC fall under?
- In its 31-03-2026 annual accounts, KANEKA EUROGENTEC states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
- What is the turnover of KANEKA EUROGENTEC?
- The turnover of KANEKA EUROGENTEC was €49.4m in financial year 2026, according to the filed annual accounts.
- Is KANEKA EUROGENTEC profitable?
- In financial year 2026, KANEKA EUROGENTEC made a loss of €20.4m.
- Where can I find the annual accounts of KANEKA EUROGENTEC?
- KANEKA EUROGENTEC filed 59 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of KANEKA EUROGENTEC due?
- KANEKA EUROGENTEC must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.